Related Experiment Video
Updated: Apr 18, 2026

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia
Published on: January 27, 2018
Eyes on MEGDEL: distinctive basal ganglia involvement in dystonia deafness syndrome
Saskia B Wortmann1, Peter M van Hasselt2, Ivo Barić3
1Department of Pediatrics, Radboudumc Amalia Children's Hospital, Nijmegen, The Netherlands.
Abstract:
Pediatric movement disorders are still a diagnostic challenge, as many patients remain without a (genetic) diagnosis. Magnetic resonance imaging (MRI) pattern recognition can lead to the diagnosis. MEGDEL syndrome (3-MethylGlutaconic aciduria, Deafness, Encephalopathy, Leigh-like syndrome MIM #614739) is a clinically and biochemically highly distinctive dystonia deafness syndrome accompanied by 3-methylglutaconic aciduria, severe developmental delay, and progressive spasticity. Mutations are found in SERAC1, encoding a phosphatidylglycerol remodeling enzyme essential for both mitochondrial function and intracellular cholesterol trafficking. Based on the homogenous phenotype, we hypothesized an accordingly characteristic MRI pattern. A total of 43 complete MRI studies of 30 patients were systematically reevaluated. All patients presented a distinctive brain MRI pattern with five characteristic disease stages affecting the basal ganglia, especially the putamen. In stage 1, T2 signal changes of the pallidum are present. In stage 2, swelling of the putamen and caudate nucleus is seen. The dorsal putamen contains an "eye" that shows no signal alteration and (thus) seems to be spared during this stage of the disease. It later increases, reflecting progressive putaminal involvement. This "eye" was found in all patients with MEGDEL syndrome during a specific age range, and has not been reported in other disorders, making it pathognomonic for MEDGEL and allowing diagnosis based on MRI findings.
Insights
MEGDEL syndrome, a rare neurological disorder, presents a unique MRI pattern in children. This distinctive finding aids in diagnosing the condition, which is caused by SERAC1 gene mutations.
Area of Science:
- Neuroimaging
- Genetics
- Pediatric Neurology
Background:
- Pediatric movement disorders often pose diagnostic challenges, with many patients lacking a genetic diagnosis.
- MEGDEL syndrome (3-MethylGlutaconic aciduria, Deafness, Encephalopathy, Leigh-like syndrome) is a distinct dystonia-deafness syndrome with severe developmental delay and spasticity.
- Mutations in the SERAC1 gene, crucial for mitochondrial function and cholesterol trafficking, underlie MEGDEL syndrome.
Purpose of the Study:
- To identify a characteristic brain MRI pattern in patients with MEGDEL syndrome.
- To determine if MRI findings can aid in the diagnosis of MEGDEL syndrome.
Main Methods:
- Systematic reevaluation of 43 complete MRI studies from 30 patients with MEGDEL syndrome.
- Analysis of MRI findings across different disease stages, focusing on the basal ganglia, particularly the putamen.
Main Results:
- A distinctive brain MRI pattern was observed in all patients, characterized by five disease stages affecting the basal ganglia.
- Early stages show T2 signal changes in the pallidum and putaminal/caudate swelling.
- A pathognomonic "eye" sign, representing a spared dorsal putamen, was identified in a specific age range, absent in other disorders.
Conclusions:
- The characteristic MRI pattern, including the unique "eye" sign, is pathognomonic for MEGDEL syndrome.
- MRI pattern recognition can facilitate diagnosis in patients with MEGDEL syndrome, even without a prior genetic diagnosis.
- This finding highlights the utility of neuroimaging in diagnosing rare pediatric movement disorders.
More Related Videos
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
05:51Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
Related Concept Videos
Alterations in Muscle Tone ll
Alterations in Muscle Tone lll
Huntington Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Neural Regulation
Parkinson's Disease: Overview